Peripheral Blood Progenitor Cell Mobilization and Neupogen Treatment
Neupogen
Dealing with advanced HIV infections and persistent neutropenia? Neupogen is the answer you’ve been looking for!
When conventional treatments fall short, Neupogen steps up, providing essential protection and peace of mind. To get the best results, Neupogen is typically given at a dosage of 0.5 MU (5 mg)/kg/day, starting at least 24 hours after cytotoxic chemotherapy. This carefully timed regimen helps keep infections at bay and improves overall health outcomes.
By choosing Neupogen, you are opting for a reliable and effective way to manage persistent neutropenia and safeguard against bacterial infections!
























